Lys-Lys-IRS-1 (891-902) (dephosphorylated) (human) is a peptide from the insulin receptor substrate 1 containing regulatory tyrosine sites in their unphosphorylated state. The sequence is valuable for studying kinase-substrate recognition and basal conformations. Researchers use it to compare phosphorylated and dephosphorylated forms in signaling assays. Its defined composition supports mechanistic pathway analysis.
CAT No: I01007
CAS No:172615-51-9
Synonyms/Alias:Lys-Lys-Insulin Receptor Substrate-1 (891-902) (dephosphorylated) (human), Lys-Lys-IRS-1 (886-897) (dephosphorylated) (mouse), Lys-Lys-IRS-1 (890-901) (dephosphorylated) (rat), IGF1RK Peptide Substrate
2. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
5. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.